Journal
CELL STEM CELL
Volume 8, Issue 5, Pages 476-478Publisher
CELL PRESS
DOI: 10.1016/j.stem.2011.04.008
Keywords
-
Categories
Ask authors/readers for more resources
We address concerns raised in this issue by Bretzner et al. (2011) by explaining the rationale for including subjects with subacute, neurologically complete spinal cord injuries in the Phase 1 trial of GRNOPC1. We also present elements of the informed consent process that minimize the likelihood of therapeutic misconception.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available